Postdoc in Translational Molecular PET Imaging in Alzheimer´s Disease


Karolinska Institutet


Stockholm, Sweden

Principal Investigator

Agneta Nordberg



A multidisciplinary team at the forefront of translational Alzheimer´s disease (AD) research with a focus on uncovering the time course of early pathological mechanisms in Alzheimer 's disease and other dementia disorders in order to develop new diagnostic biomarkers and drug targets for treatment is looking for a talented and highly motivated young scientist researcher with interest in applying new molecular imaging positron emission tomography (PET) techniques to characterize and quantify pathological changes and molecular signaling mechanisms in the brains of individuals with different neurodegenerative disorders, with a special focus on AD. Proteinopathies are a common feature of neurodegenerative disorder, so the research aims to understand the characteristics of different midfolded proteins, including amyloidosis, tau, non-neuronal astroglia cells and functional α7 receptor proteins and how they interact and can be studied in brain by positron emission tomography (PET) in multi-tracer PET design.The environment provides excellent postdoctoral training in an international working environment, national and international collaborations, and possibilities to publish in high-impact journals.


Applicants must have obtained a Ph.D. no more than three years from the application deadline and have well-documented research experience in the field of imaging with some statistical and modelling experience. Experience in translational brain studies including in vitro autoradiography is appreciated.

The position is full time for two years, and is available immediately.